Scarica l'app Stockscreener
76.49
1.53%
1.15
Dopo l'orario di chiusura:
76.40
-0.09
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$75.34
Aprire:
$74.82
Volume 24 ore:
126.19K
Relative Volume:
1.18
Capitalizzazione di mercato:
$3.24B
Reddito:
$1.50B
Utile/perdita netta:
$87.58M
Rapporto P/E:
25.08
EPS:
3.05
Flusso di cassa netto:
$111.36M
1 W Prestazione:
-2.39%
1M Prestazione:
-1.30%
6M Prestazione:
+3.36%
1 anno Prestazione:
+30.35%
Intervallo 1D:
$74.44
$76.81
Intervallo di 1 settimana:
$74.44
$78.92
Portata 52W:
$55.02
$82.99
Sensient Technologies Corp Stock (SXT) Company Profile
Nome
Sensient Technologies Corp
Settore
Industria
Telefono
(414) 271-6755
Indirizzo
777 EAST WISCONSIN AVENUE, MILWAUKEE
Sensient Technologies Corp Stock (SXT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-10-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-10-10 | Aggiornamento | Sidoti | Neutral → Buy |
| 2021-05-27 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-10 | Iniziato | Stephens | Overweight |
| 2019-10-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
| 2019-02-21 | Iniziato | Seaport Global Securities | Buy |
| 2019-02-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-01-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2018-02-12 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-09-22 | Iniziato | Berenberg | Buy |
| 2016-07-25 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-02-08 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2015-03-31 | Iniziato | BB&T Capital Mkts | Buy |
| 2011-02-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2011-01-12 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
| 2009-04-21 | Reiterato | KeyBanc Capital Mkts | Buy |
| 2008-12-23 | Reiterato | KeyBanc Capital Mkts | Buy |
| 2008-07-09 | Aggiornamento | KeyBanc Capital Mkts | Hold → Buy |
| 2008-04-22 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
| 2008-04-15 | Iniziato | Oppenheimer | Outperform |
| 2007-07-31 | Aggiornamento | KeyBanc Capital Mkts / McDonald | Hold → Buy |
| 2007-02-13 | Downgrade | KeyBanc Capital Mkts / McDonald | Buy → Hold |
Mostra tutto
Sensient Technologies Corp Borsa (SXT) Ultime notizie
There May Be Some Bright Spots In Sensient Technologies' (NYSE:SXT) Earnings - Yahoo Finance
Ex-Dividend Reminder: Sensient Technologies, Baker Hughes and Cheniere Energy Partners - Nasdaq
Sensient Technologies (NYSE:SXT) Upgraded by StockNews.com to Buy - MarketBeat
Sensient Technologies' (NYSE:SXT) Dividend Will Be $0.41 - Yahoo Finance
Boston Trust Walden Corp Has $42.28 Million Stock Holdings in Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Sensient Technologies Third Quarter 2024 Earnings: EPS: US$0.78 (vs US$0.75 in 3Q 2023) - Yahoo Finance
Sensient Technologies Corporation (NYSE:SXT) Q3 2024 Earnings Call Transcript - Insider Monkey
Sensient Technologies Reports Strong Q3 2024 Performance - Yahoo Finance
Sensient Technologies Corp (SXT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Sensient Technologies Corp (SXT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Sensient Technologies Corp (SXT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins - GuruFocus.com
Sensient: Q3 Earnings Snapshot - Houston Chronicle
Earnings call: Sensient Technologies reports robust Q3 growth By Investing.com - Investing.com South Africa
Earnings call: Sensient Technologies reports robust Q3 growth - Investing.com
Sensient Technologies Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
Sensient Technologies (NYSE:SXT) Updates FY 2024 Earnings Guidance - MarketBeat
Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2024 - Yahoo Finance
Sensient Declares Dividend - Yahoo Finance
An Overview of Sensient Technologies's Earnings - Benzinga
Sensient Technologies (SXT) Scheduled to Post Quarterly Earnings on Friday - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Holdings in Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Estimating The Intrinsic Value Of Sensient Technologies Corporation (NYSE:SXT) - Simply Wall St
Sensient Announces Conference Call - Lelezard
Squarepoint Ops LLC Sells 7,127 Shares of Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Seed Coating Market to cross USD 1.45 Billion by 2032, Says Global Market Insights inc. - GlobeNewswire Inc.
Kimelman & Baird LLC Purchases Shares of 17,350 Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Sensient Technologies Co. (NYSE:SXT) Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Sensient Technologies' (NYSE:SXT) Returns Have Hit A Wall - Yahoo Finance
State of New Jersey Common Pension Fund D Cuts Stock Position in Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Semrush director sells over $1.6 million in company stock - Investing.com
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
SAF-Holland (ETR:SFQ) Share Price Crosses Below Fifty Day Moving Average of $17.75 - Defense World
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Massachusetts Financial Services Co. MA Sells 444,049 Shares of Sensata Technologies Holding plc (NYSE:ST) - MarketBeat
Eversense 365, a 1-Year CGM, Cleared by the FDA - diaTribe Foundation
FDA Clears First 1-Year CGM for Diabetes - Drug Topics
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes - MD Magazine
WINTON GROUP Ltd Purchases Shares of 7,158 Sensient Technologies Co. (NYSE:SXT) - MarketBeat
Senseonics and Ascensia announce FDA approval for one-year CGM system - Medical Device Network
FDA Clears Eversense® 365: The World’s First One-Year CGM System - HIT Consultant
FDA clears Senseonic’s Eversense one-year implantable CGM - BioWorld Online
Eversense 365 Continuous Glucose Monitoring System Receives FDA Clearance: The First One-Year CGM - Beyond Type 1
FDA Approves Glucose Monitor That Can Be Worn for a Year - Yahoo Finance
FDA Clears First 1-Year Continuous Glucose Sensor - Medscape
Long-Term CGM System Eversense 365 Gets FDA Clearance - Monthly Prescribing Reference
Senseonics Wins FDA Clearance for Year-Long CGM - MD+DI
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Senseonics receives FDA clearance for one-year CGM - MedTech Dive
Senseonics wins FDA nod for 365-day implantable CGM - Mass Device
Sensient Technologies Corp Azioni (SXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):